Fonar Corp (FONR) Stock Price & Analysis
Fonar Corp (FONR) rose 0.00% to USD 19.09 as of June 10, 2026 at 10:14 UTC, according to Nexqual real-time market data.
FONR last closed at USD 0; the session ranged USD 19.09–19.13 on volume of 935,991 shares. Market capitalization is $120.20M, with a 52-week range of USD 13.62–19.16 (NGM). Source: Nexqual, June 10, 2026 at 10:14 UTC.
Key Statistics (as of June 10, 2026 at 10:14 UTC)
| Price | USD 19.09 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 19.09 |
| Day Range | USD 19.09 – 19.13 |
| 52-Week Range | USD 13.62 – 19.16 |
| Volume | 935,991 shares |
| Market Cap | $120.20M |
| Exchange | NGM |
Technical Analysis (FONR)
Nexqual's technical model rates FONR "BUY" based on 5 bullish and 1 bearish signals across 120 daily candles, as of June 10, 2026 at 10:14 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 76.79 (overbought) |
| vs SMA50 | Above (USD 18.81) |
| MACD | 0.08 (positive) |
Analyst Ratings (FONR)
Wall Street analysts rate FONR "None", per Nexqual as of June 10, 2026 at 10:14 UTC.
| Consensus Rating | None |
|---|
Earnings (FONR)
| Next Earnings Date | 2026-05-14 |
|---|
Source: Nexqual, June 10, 2026 at 10:14 UTC.
Financials & Fundamentals (FONR)
| Total Revenue | $105.34M |
|---|---|
| Revenue Growth (YoY) | -2.60% |
| Gross Margin | +40.26% |
| Operating Margin | +9.23% |
| Profit Margin | +6.35% |
| ROE | +5.47% |
| Debt / Equity | 23.61 |
| Current Ratio | 9.18 |
| Total Cash | $53.77M |
| Total Debt | $38.83M |
| Free Cash Flow | $1.07M |
Source: Nexqual, June 10, 2026 at 10:14 UTC.
Financial Health Score (FONR)
Nexqual rates Fonar Corp's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 10:14 UTC.
| Growth | Weak — Revenue -3% YoY (latest Q), declining |
|---|---|
| Profitability | Strong — Gross margin 40%, operating 9% |
| Balance Sheet | Strong — $54M cash vs $39M debt, net cash position |
| Cash Flow | Mixed — FCF $1M, slim 1.0% margin |
| Efficiency | Mixed — ROE 5%, ROA 2.7% |
Ownership (FONR)
| Insider Ownership | +16.33% |
|---|---|
| Institutional Ownership | +40.34% |
| Shares Outstanding | 6.17M |
| Float | 5.48M |
| Short % of Float | +1.09% |
Source: Nexqual, June 10, 2026 at 10:14 UTC.
Leadership (FONR)
Fonar Corp is led by Timothy R. Damadian (age 61), Chairman, President, CEO & Treasurer, per Nexqual as of June 10, 2026 at 10:14 UTC.
| Chairman, President, CEO & Treasurer | Timothy R. Damadian (age 61) |
|---|---|
| COO, Executive VP & Acting Principal Financial Officer | Luciano Benedetto Bonanni (age 70) |
| Director of Communications | Daniel Culver |
Major Backers & Investors (FONR)
Notable institutional backers of Fonar Corp include Money Concepts Capital Corporation, FNY Investment Advisers, LLC, DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Value Portfolio, according to Nexqual as of June 10, 2026 at 10:14 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Money Concepts Capital Corporation | 8.06% |
| FNY Investment Advisers, LLC | 4.1% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Value Portfolio | 3.37% |
| Groupe La Francaise | 1.92% |
| Peapod Lane Capital LLC | 1.84% |
| Gabelli Funds, LLC | 1.47% |
| RBF Capital, LLC | 1.45% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 10.68% |
| Dimensional Fund Advisors | 5.73% |
| BlackRock | 1.48% |
Source: Nexqual, June 10, 2026 at 10:14 UTC.
From Fonar Corp's Latest SEC 10-K Filing (filed 2025-09-22)
Key Strengths & Strategy (as disclosed to the SEC)
- Service and maintenance revenues from our external installed base were approximately $8.4 million in fiscal 2025 and $7.6 million in fiscal 2024.   We hope to maintain service revenues at present levels, based on the demonstrated longevity of the Upright® MRI scanner and continued customer satisfaction with the product.
- Damadian's pioneer patent that initiated the MRI industry and provided the original invention of MRI scanning.   We maintain a robust patent portfolio that provides us, under the aegis of United States patent law, "the exclusive right to make, use and sell" many of the scanner features which FONAR pioneered and which are now incorporated in most MRI scanners sold by the industry.
- We believe that these patents, and the know-how we have developed, are material to our business.   Page 16       FONAR CORPORATION AND SUBSIDIARIES   Our seminal patent, issued in the name of Dr.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IRIX | IRIDEX Corporation | USD 1.12 | ▲ 2.75% |
| PDEX | Pro-Dex, Inc. | USD 65 | ▼ 0.32% |
| ESCA | Escalade, Incorporated | USD 18.2 | ▲ 1.68% |
| FUNC | First | USD 40.96 | ▲ 3.12% |
| FNLC | First Bancorp, Inc (ME) | USD 30.06 | ▲ 0.84% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 10:14 UTC. This page is informational and not investment advice.